Stem Cell Banking Market Size

  • Report ID: 4776
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Stem Cell Banking Market Outlook:

Stem Cell Banking Market size was over USD 8.93 billion in 2025 and is projected to reach USD 34.59 billion by 2035, growing at around 14.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of stem cell banking is evaluated at USD 10.1 billion.

The growth of the market can be attributed to growing investment in stem cell research by number of nations owing to stem cell capacity to completely transform the way diseases are treated in people. The Novo Nordisk Foundation was anticipated to contribute up to USD 340 million over ten years to the creation of a worldwide stem cell research facility in 2022. Moreover, stem cell is a complex and continuous to conduct research on. Therefore, this factor is also anticipated to boost the investment on stem cell research.

Moreover, there has been growing need for stem cell transplant all across the world. Around 12 lakh transplants have been performed utilizing stem cells globally during the past 50 years. Presently, there are more than 49,000 transplants performed annually, and the number is rising. However, stem cells still need to be kept in reserve for potential autologous or allogeneic applications, even when they are employed for medical treatments. Through using this method, less human tissues would be used, and more studies could be compared. Hence, stem cell banks have been set up for both current research and therapy, raising some ethical, legal, and social concerns in the process. Hence, owing to this stem cell banking market is estimated to grow.


Stem Cell Banking Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of stem cell banking is evaluated at USD 10.1 billion.

The global stem cell banking market size was worth over USD 8.93 billion in 2025 and is poised to grow at a CAGR of around 14.5%, reaching USD 34.59 billion revenue by 2035.

North America stem cell banking market will hold over 36.1% share by 2035, fueled by growing prevalence of chronic disease, well-established medical infrastructure, and rising genetic problems, reproduction-related disorders, and infertility.

Key players in the market include CBR Systems Inc., Global Cord Blood Corporation, Cordlife Group Limited, Cordvidadvdfvdsfsdf, Cryo-Cell International, Inc., BrainStorm Cell Limited, Cryoviva Biotech Pvt. Ltd., Lifecell International Private Limited, Smart Cells International Ltd, Viacord, LLC.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos